Download COPD Collaborative Care

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts

Bag valve mask wikipedia , lookup

Transcript
Chronic Obstructive Pulmonary Disease
(COPD)
COPD
Description
Characterized by presence of airflow obstruction
 Caused by emphysema or chronic bronchitis
 Generally progressive
 May be accompanied by airway hyperreactivity
 May be partially reversible

Emphysema
Description

Abnormal permanent enlargement of the air space distal to the
terminal bronchioles

Accompanied by destruction of bronchioles
Chronic Bronchitis
Description

Presence of chronic productive cough for
3 or more months in each of 2 successive years in a patient whom
other causes of chronic cough have been excluded
COPD
Causes

Cigarette smoking
 Primary cause of COPD***
 Clinically significant airway obstruction develops in 15% of
smokers
 80% to 90% of COPD deaths are related to tobacco smoking
 > 1 in 5 deaths is result of cigarette smoking
COPD
Causes

Cigarette smoking
 Nicotine stimulates sympathetic nervous system resulting in:



 HR
Peripheral vasoconstriction
 BP and cardiac workload
COPD
Causes

Cigarette smoking
 Compounds problems in a person with CAD
  Ciliary activity
 Possible loss of ciliated cells
 Abnormal dilation of the distal air space
 Alveolar wall destruction
 Carbon monoxide



 O2 carrying capacity
Impairs psychomotor performance and judgment
Cellular hyperplasia



Production of mucus
Reduction in airway diameter
Increased difficulty in clearing secretions
COPD
Causes

Secondhand smoke exposure associated with:
  Pulmonary function
  Risk of lung cancer
  Mortality rates from ischemic heart disease
COPD
Causes


Infection
 Major contributing factor to the aggravation and progression of COPD
Heredity
 -Antitrypsin (AAT) deficiency (produced by liver and found in lungs);
accounts for < 1% of COPD cases

Emphysema results from lysis of lung tissues by proteolytic enzymes from neutrophils and
macrophages
Pathophysiology of Chronic Bronchitis and
Emphysema
Emphysema
Pathophysiology
 Hyperinflation
of alveoli
 Destruction of alveolar walls
 Destruction of alveolar capillary walls
 Narrowed airways
 Loss of lung elasticity
Emphysema
Pathophysiology
 Two
types:
 Centrilobular (central part of lobule)
 Most common

Panlobular (destruction of whole lobule)
 Usually associated with AAT deficiency
Emphysema
Pathophysiology

Structural changes are:
 Hyperinflation of alveoli
 Destruction of alveolar capillary walls
 Narrowed, tortuous small airways
 Loss
of lung elasticity
Emphysema
Pathophysiology

Small bronchioles become obstructed as a result of





Mucus
Smooth muscle spasm
Inflammatory process
Collapse of bronchiolar walls
Recurrent infections
production/stimulation of neutrophils and
macrophages
release proteolytic enzymes alveolar destruction
inflammation, exudate, and edema
Emphysema
Pathophysiology
 Elastin
and collagen are destroyed
 Air goes into the lungs but is unable to come out on its own and
remains in the lung
 Causes bronchioles to collapse
Emphysema
Pathophysiology
Trapped air  hyperinflation and overdistention
 As more alveoli coalesce, blebs and bullae may develop
 Destruction of alveolar walls and capillaries  reduced surface area for
O2 diffusion
 Compensation is done by increasing respiratory rate to increase alveolar
ventilation
 Hypoxemia usually develops late in disease

Emphysema
Clinical Manifestations
 Dyspnea
Progresses in severity
 Patient will first complain of dyspnea on exertion and
progress to interfering with ADLs and rest

Emphysema
Clinical Manifestations
 Minimal
coughing with no to small amounts of sputum
 Overdistention
of alveoli causes diaphragm to flatten and AP
diameter to increase
Emphysema
Clinical Manifestations
 Patient
becomes chest breather, relying on accessory muscles
 Ribs become fixed in inspiratory position
Emphysema
Clinical Manifestations
 Patient
is underweight (despite adequate calorie intake)
Chronic Bronchitis
Pathophysiology
Pathologic lung changes are:
 Hyperplasia of mucus-secreting glands
in trachea and bronchi
 Increase in goblet cells
 Disappearance of cilia
 Chronic inflammatory changes and narrrowing of small airways
 Altered fxn of alveolar macrophages
infections
Chronic Bronchitis
Pathophysiology
Chronic inflammation
 Primary pathologic mechanism causing changes

Narrow airway lumen and reduced airflow d/t
 hyperplasia of mucus glands
 Inflammatory swelling
 Excess, thick mucus
Chronic Bronchitis
Pathophysiology
 Greater
resistance to airflow increases work of breathing
 Hypoxemia
and hypercapnia develop more frequently in
chronic bronchitis than emphysema
Chronic Bronchitis
Pathophysiology
Bronchioles are clogged with mucus and pose a physical
barrier to ventilation
 Hypoxemia and hypercapnia d/t lack of ventilation and O2
diffusion
 Tendency to hypoventilate and retain CO2
 Frequently patients require O2 both at rest and during exercise

Chronic Bronchitis Pathophysiology
 Cough
is often ineffective to remove secretions because the
person cannot breathe deeply enough to cause air flow distal to
the secretions
 Bronchospasm frequently develops
 More common with history of smoking or asthma
Chronic Bronchitis
Clinical Manifestations
 Earliest
symptoms:
Frequent, productive cough during winter
 Frequent respiratory infections

Chronic Bronchitis
Clinical Manifestations
Bronchospasm at end of paroxysms of coughing
 Cough
 Dyspnea on exertion
 History of smoking
 Normal weight or heavyset
 Ruddy (bluish-red) appearance d/t



polycythemia (increased Hgb d/t chronic hypoxemia))
cyanosis
Chronic Bronchitis
Clinical Manifestations
 Hypoxemia
and hypercapnia
 Results from hypoventilation and  airway resistance +
problems with alveolar gas exchange
COPD
Complications
Pulmonary hypertension (pulmonary vessel constriction d/t alveolar
hypoxia & acidosis)
 Cor pulmonale (Rt heart hypertrophy + RV failure)
 Pneumonia
 Acute Respiratory Failure

COPD
Diagnostic Studies
Chest x-rays early in the disease may not show abnormalities
 History and physical exam


Pulmonary function studies
 reduced FEV1/FVC and  residual volume and total lung
capacity
COPD
Diagnostic Studies

ABGs
  PaO2
  PaCO2 (especially in chronic bronchitis)
  pH (especially in chronic bronchitis)
  Bicarbonate level found in late stages COPD
COPD
Collaborative Care

Smoking cessation
 Most significant factor in slowing the progression of the disease
COPD
Collaborative Care: Drug Therapy

Bronchodilators – as maintenance therapy
 -adrenergic agonists (e.g. Ventolin)

MDI or nebulizer preferred
 Anticholinergics
(e.g. Atrovent)
COPD
Collaborative Care:
Oxygen Therapy

O2 therapy
 Raises PO2 in inspired air
 Treats hypoxemia
 Titrate
to lowest effective dose
COPD
Collaborative Care:
Oxygen Therapy
 Chronic
O2 therapy at home
Improved prognosis
 Improved neuropsychologic function
 Increased exercise tolerance
 Decreased hematocrit
 Reduced pulmonary hypertension

COPD
Collaborative Care: Respiratory Therapy
 Breathing
retraining
 Pursed-lip

breathing
Prolongs exhalation and prevents bronchiolar collapse and air trapping
 Diaphragmatic

breathing
Focuses on using diaphragm instead of accessory muscles to achieve
maximum inhalation and slow respiratory rate

See text re how to teach
COPD
Collaborative Care: Respiratory Therapy
Huff coughing (Table 28-21)
 Chest physiotherapy – to bring secretions into larger, more
central airways
 Postural drainage
 Percussion
 Vibration

Positions for Postural Drainage
COPD
Collaborative Care
 Encourage
patient to remain as active
as possible
COPD
Collaborative Care

Surgical Therapy
 Lung volume reduction surgery
 Lung transplant
COPD
Collaborative Care

Nutritional therapy
Full stomachs press on diaphragm causing dyspnea and discomfort
 Difficulty eating and breathing at the same time leads to inadequate
amounts being eaten

COPD
Collaborative Care

Nutritional therapy







To decrease dyspnea and conserve energy
Rest at least 30 minutes prior to eating
Use bronchodilator before meals
Select foods that can be prepared in advance
5-6 small meals to avoid bloating
Avoid foods that require a great deal of chewing
Avoid exercises and treatments 1 hour before and after eating
COPD
Collaborative Care
 Nutritional

therapy
Avoid gas-forming foods
High-calorie, high-protein diet is recommended
 Supplements
 Avoid high carbohydrate diet to prevent increase in CO2 load

Nursing Management
Nursing Diagnoses
Ineffective airway clearance
 Impaired gas exchange
 Imbalanced nutrition: less than body requirements
 Disturbed sleep pattern
 Risk for infection

Nursing Management
Nursing Implementation
Health Promotion
 STOP SMOKING!!!
 Avoid or control exposure to occupational and environmental
pollutants and irritants
 Early detection of small-airway disease
 Early diagnosis of respiratory tract infections
Nursing Management
Nursing Implementation
Acute Intervention
 Required for complications like pneumonia, cor pulmonale, and
acute respiratory failure
Nursing Management
Nursing Implementation
Ambulatory and Home Care
 Pulmonary rehabilitation
 Control and alleviate symptoms of pathophysiologic
complications of respiratory impairment
Nursing Management
Nursing Implementation
Ambulatory and Home Care
 Teach patient how to achieve optimal capability in carrying out ADLs




Physical therapy
Nutrition
Education
Activity considerations

Exercise training of upper extremities to help improve function and relieve
dyspnea
Nursing Management
Nursing Implementation
n
n
Ambulatory and Home Care
Explore alternative methods of ADLs
Encourage patient to sit while
performing activities
 Coordinated walking

Nursing Management
Nursing Implementation
Ambulatory and Home Care
 Slow, pursed-lip breathing
 After exercise, wait 5 minutes before using -adrenergic agonist
MDI
Nursing Management
Nursing Implementation
Ambulatory and Home Care
 Sexual activity
Plan during part of day when breathing is best
 Slow, pursed-lip breathing

 Refrain
after eating or other strenuous activity
 Do not assume dominant position
 Do not prolong foreplay
Nursing Management
Nursing Implementation
Ambulatory and Home Care
 Sleep
Nasal saline sprays
 Decongestants
 Nasal steroid inhalers
 Long-acting theophylline


Decreases bronchospasm and airway obstruction
Nursing Management
Nursing Implementation
Ambulatory and Home Care
 Psychosocial considerations
Guilt
 Depression
 Anxiety
 Social isolation
 Denial
 Dependence
 Use relaxation techniques and support groups

Nursing Management
Nursing Implementation
Ambulatory and Home Care
 Discourage moving to places above 4000 ft.